Clinical trial
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
NCT06843304 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2024
- Completion date
- December 31, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic nephropathy, t2dm